Next Article in Journal
Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the Toolbox
Next Article in Special Issue
CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma
Previous Article in Journal
Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC)
Previous Article in Special Issue
A Novel AURKA Mutant-Induced Early-Onset Severe Hepatocarcinogenesis Greater than Wild-Type via Activating Different Pathways in Zebrafish
 
 
Review

Article Versions Notes

Cancers 2019, 11(8), 1086; https://doi.org/10.3390/cancers11081086
Action Date Notes Link
article xml file uploaded 31 July 2019 14:03 CEST Original file -
article pdf uploaded. 31 July 2019 14:03 CEST Version of Record https://www.mdpi.com/2072-6694/11/8/1086/pdf-vor
article supplementary file uploaded. 31 July 2019 14:03 CEST - https://www.mdpi.com/2072-6694/11/8/1086#supplementary
article xml file uploaded 6 August 2019 07:36 CEST Update -
article xml uploaded. 6 August 2019 07:36 CEST Update https://www.mdpi.com/2072-6694/11/8/1086/xml
article pdf uploaded. 6 August 2019 07:36 CEST Updated version of record https://www.mdpi.com/2072-6694/11/8/1086/pdf
article supplementary file uploaded. 6 August 2019 07:36 CEST - https://www.mdpi.com/2072-6694/11/8/1086#supplementary
article html file updated 6 August 2019 07:37 CEST Original file -
article html file updated 28 August 2019 04:47 CEST Update -
article html file updated 13 February 2020 06:20 CET Update -
article html file updated 20 July 2022 06:03 CEST Update https://www.mdpi.com/2072-6694/11/8/1086/html
Back to TopTop